LT - Oksazol[4,5-B]piridino ir tiazol[4,5-B]piridino darinių, kaip IRAK4 inhibitorių, skirtų vėžio gydymui, gamybos būdas
EN - METHOD OF PREPARING OXAZOLO[4,5-B]PYRIDINE AND THIAZOLO[4,5-B]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS FOR TREATING CANCER
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 498/04 |
(2006.01) |
|
|
C07D 513/04 |
(2006.01) |
|
|
C07D 519/00 |
(2006.01) |
|
|
A61K 31/437 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3466955 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
18190333.7 |
|
Date of filing the European patent application |
2015-01-12 |
| (97) |
Date of publication of the European application |
2019-04-10 |
| (45) |
Date of publication and mention of the grant of the patent |
2020-12-16
|
| (46) |
Date of publication of the claims translation |
2021-02-25
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
158CH2014 |
2014-01-13
|
IN |
|
3000CH2014 |
2014-06-20
|
IN |
Inventors
| (72) |
GUMMADI, Venkateshwar, Rao, IN
SAMAJDAR, Susanta, IN
|
Grantee
| (73) |
Aurigene Oncology Limited ,
39-40 KIADB Industrial Area
Electronic City Phase II
Hosur Road, Bangalore 560100,
IN
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Oksazol[4,5-B]piridino ir tiazol[4,5-B]piridino darinių, kaip IRAK4 inhibitorių, skirtų vėžio gydymui, gamybos būdas |
| |
METHOD OF PREPARING OXAZOLO[4,5-B]PYRIDINE AND THIAZOLO[4,5-B]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS FOR TREATING CANCER |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-12-18 |
11 |
289.00
EUR
|
Next renewal fee
|
2026-01-12 |
